Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Bone Marrow Transplantation|April 13, 2022
Autologous stem cell transplantation for multiple myeloma patients with chronic kidney disease: a safe and effective optionI Lazana, L Floro, T Christmas, et al.
Leukemia & Lymphoma|November 9, 2001
Liposomal daunorubicin (DaunoXome) in combination with cyclophosphamide, vincristine and prednisolone (COP-X) as salvage therapy in poor-prognosis non-Hodgkins lymphomaN C McBride, J D Cavenagh, M C Ward, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Prospective randomised study of double hemi-body irradiation with and without subsequent maintenance recombinant alpha 2b interferon on survival in patients with relapsed multiple myelomaF J Giles, E N McSweeney, J D Richards, et al.
Leukemia|May 23, 2001
Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemiaG Visani, D Milligan, F Leoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2004
Phase II study of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C alpha, in patients with previously treated low-grade non-Hodgkin's lymphomaS Rao, D Watkins, D Cunningham, et al.
The British Journal of Dermatology|January 26, 2006
Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretinE Campalani, M H Allen, D Fairhurst, et al.
British Journal of Haematology|February 13, 2001
A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformationG Jackson, P Taylor, G M Smith, et al.
Cytotherapy|August 13, 2002
In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantationP D Kottaridis, D W Milligan, R Chopra, et al.
Blood|September 26, 2000
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantationP D Kottaridis, D W Milligan, R Chopra, et al.
Pageof 8